COVID-19: Vaccines and Therapeutics

This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
President Biden today took a number of actions, including signing a series of executive orders (EOs), aimed at addressing the COVID-19 pandemic.
The Food and Drug Administration updated its guidance and webpage on COVID-19 convalescent plasma.
The American Medical Association announced Current Procedural Terminology codes for reporting the single-dose Janssen (Johnson & Johnson) COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency…
The Department of Health and Human Services announced a $20 million investment in several initiatives that will help increase data sharing between health information exchanges and immunization information systems.
President-elect Joe Biden named former Food and Drug Administration commissioner David Kessler, M.D., as Chief Science Officer of COVID Response, a role that will assume the responsibilities of the current head of Operation Warp Speed, the Trump administration effort focused on the development and…
President-elect Biden unveiled plans for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems. Biden hopes that Congress will consider the legislation soon after he is inaugurated next week.